LKT Labs

Biochemicals for Life Science Research

Cyclovirobuxine D

Cyclovirobuxine D

Product ID C9711
Cas No. 860-79-7
Purity ≥97%
Product Unit SizeCostQuantityStock
25 mg $102.00 In stock
100 mg $254.80 In stock
500 mg $1,006.30 In stock
Bulk Quote

Quicklinks

Description

Cyclovirobuxine D is originally found in Buxus and displays cardioprotective and anticancer activities. Cyclovirobuxine inhibits the viability of breast cancer cells, inhibiting phosphorylation of Akt and mTOR and inducing autophagy. This compound also shows benefit in the treatment of heart failure but may prolong the QT interval through inhibition of human ether-a-go-go-related (hERG) K+ channel currents. Additionally, cyclovirobuxine D decreases infarct size and venous thrombus size in animal models of myocardial ischemia.

Product Info

Cas No.

860-79-7
Purity

≥97%
Formula

C26H46N2O
Formula Wt.

402.66
IUPAC Name

C26H46N2O
Synonym

Bebuxine, Cyclovirobuxine
Melting Point

219-224°C
Appearance

White crystal

Shipping and Storage

Store Temp

4°C
Ship Temp

Ambient

Downloads

MSDS

C9711 MSDS PDF
Info Sheet

C9711 Info Sheet PDF

References

Lu J, Sun D, Gao S, et al. Cyclovirobuxine D induces autophagy-associated cell death via the Akt/mTOR pathway in MCF-7 human breast cancer cells. J Pharmacol Sci. 2014;125(1):74-82. PMID: 24758922.

Yu B, Fang TH, Lü GH, et al. Beneficial effect of Cyclovirobuxine D on heart failure rats following myocardial infarction. Fitoterapia. 2011 Sep;82(6):868-77. PMID: 21575690.

Zhao J, Wang Q, Xu J, et al. Cyclovirobuxine D inhibits the currents of HERG potassium channels stably expressed in HEK293 cells. Eur J Pharmacol. 2011 Jun 25;660(2-3):259-67. PMID: 21497594.

Hu D, Liu X, Wang Y, et al. Cyclovirobuxine D ameliorates acute myocardial ischemia by K(ATP) channel opening, nitric oxide release and anti-thrombosis. Eur J Pharmacol. 2007 Aug 13;569(1-2):103-9. PMID: 17555743.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • N1981

    Neuromedin C (18-27), pig

    Endogenous bombesin-related peptide, involved in e...
    ≥98%
  • C0006

    Cabozantinib

    VEGFR2, c-Met, RET inhibitor.
    ≥98%
  • S3568

    Siramesine

    σ2 agonist.
    ≥98%
  • E5216

    β-Endorphin, camel

    Endogenous opioid peptide; μOR agonist.
    ≥95%
  • H1894

    Hexestrol

    Synthetic catechol; ER agonist, microtubule polyme...
    ≥98%
  • AS105

    Buckthorn Standards Kit

    Buckthorn Standards Kit Contents: -Column: Cosmosi...
  • AS107

    Caffeic Acid Esters Standards Kit

    Caffeic Acid Esters Standards Kit Contents: -Colum...
  • S0928

    SCH-900776

    CHK1 inhibitor.
    ≥98%
  • T1673

    Terlipressin Acetate

    Synthetic peptide, vasopressin analog; AVPR1 agoni...
    ≥95%
  • T0115

    Taxol Side Chain Acid

    Side chain commonly attached to taxanes.
    ≥98%
  • P0370

    Paromomycin Sulfate

    Aminoglycoside; protein translation inhibitor, cat...
    ≥98%
  • L9602

    LY-2874455

    FGFR inhibitor.
    ≥98%
  • G0247

    2″O-Galloylhyperin

    Flavonoid glycoside found in Pyrola.
    ≥98%
  • N5669

    Nordihydroguaiaretic Acid

    Phenol found in the creosote bush; 5-lipoxygenase,...
    ≥97%
  • P4492

    PLX4720

    V600E B-Raf inhibitor.
    ≥98%
  • B1640

    Benzydamine Hydrochloride

    NSAID; PG synthetase inhibitor.
    ≥98%
  • C0271

    Carfilzomib

    Epoxomicin analog; proteasome inhibitor.
    ≥98%
  • M3577

    Mitiglinide Calcium

    ATP-sensitive K+ channel blocker, potential RyR ag...
    ≥98%
  • G0147

    Galanin, pig

    Endogenous neuropeptide, involved in nociception, ...
    ≥98%
  • P2992

    Phyllolitorin

    Peptide found in amphibian skin; GRP (BB1) and neu...
    ≥95%